| pursuant to Section 96 of the Companies Act, 2013, read with Regulation 30 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements), 2015, pursuant to the Circular No. 14/2020 dated April 08, 2020, Circular No. 17/2020 dated April 13, 2020 issued by the Ministry of Corporate Affairs followed by the Circular No. 20/2020 dated May 05,2020, the 34th Annual General Meeting of the Company will held on Monday, 16th day of May, 2022 at 03.30 PM through Video Conferencing and Other Audio Visual Means (VC & OAVM).
Outcome of the 34th Annual General Meeting held on 16.05.2022 at 03:30 P.M. through Video Conferencing and Other Audio Visual Means.
(As per BSE Announcement Dated on 16/5/2022)
Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the members of the Company have approved all the resolutions bearing item no. 1 to 7 contained in the Notice of 34th Annual General Meeting of the Company with requisite majority. The Company had appointed Mrs. Vidya Harkut partner at VSS & Associates Company Secretaries as the Scrutinizer for remote e-voting for the AGM. The Scrutinizer has submitted his report on 18.05.2022. In this connection we hereby enclose the results of the remote e-voting in the format prescribed together with the Scrutinizers Report.
(As Per BSE Announcement dated on 18.05.2022)
Godavari Drugs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015.
(As per BSE Announcement Dated on 19/5/2022) |
